Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Olink, Biognosys

Premium

Olink Bioscience this week launched its new Proseek Multiplex CVD protein biomarker panel.

Intended for research into cardiovascular disease, the panel allows for analysis of 92 CVD-related proteins across 96 samples simultaneously using as little as one microliter per sample, the company said. The panel uses Olink's Proseek Multiplex technology combined with Fluidigm's BioMark HD system.


Biognosys this week released a new version of its iRT kit for use in calibrating mass spec runs including shotgun and scheduled MRM experiments.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more